Меню
Набор скоро начнётся NCT07267780

Contribution of Oncovascular Surgery in the Treatment of Gynecological Advanced Malignant Diseases.

— Наблюдательное Ovarian Carcinoma Cervical Carcinoma Endometrial Carcinoma Vulvar Carcinoma

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
Это наблюдательное исследование: исследуемое лечение участникам по протоколу не назначают.
Кому может быть актуально
Состояния в реестре: Ovarian Carcinoma, Cervical Carcinoma, Endometrial Carcinoma, Vulvar Carcinoma. Базовые параметры: от 18 лет · Женщины.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
Италия
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →

Не всё понятно в терминах? Прочитайте наш гид для пациентов →

Официальное название

The Contribution of Oncovascular Surgery in the Treatment of Gynecological Advanced Malignant Diseases: a Prospective and Retrospective Multicenter Study

Обзор

Multicenter ambispective observational study (prospective/retrospective)

Подробное описание

This multicenter ambispective observational study, including both a retrospective phase (patients treated surgically between January 1, 2017, and August 31, 2025) and a prospective phase, aims to evaluate the role of onco-vascular surgery in the treatment of advanced and recurrent gynecologic cancers. Onco-vascular surgery involves the simultaneous resection and reconstruction of major blood vessels when the tumor infiltrates or adheres firmly to them, and its benefits have been demonstrated in other malignancies such as hepatobiliary-pancreatic cancers and retroperitoneal soft tissue sarcomas. In the context of gynecologic oncology, this surgical approach is an emerging field with the potential to increase the rate of complete (R0) resection without increasing morbidity or mortality. However, data on the frequency, safety, and oncologic outcomes of vascular surgery in gynecologic oncology remain limited.

The study collects data on patient demographics, tumor characteristics, surgical details, postoperative complications, adjuvant therapies, oncologic outcomes, and quality of life (EORTC QLQ-C30).

Primary Objective: To describe overall survival in patients with advanced or recurrent gynecologic cancers undergoing onco-vascular surgery. Additionally, survival outcomes-including overall survival and 5-year progression-free survival-will be assessed for each patient subgroup, stratified by gynecologic cancer type and disease status (initial diagnosis vs. recurrence).

Первичные конечные точки

  • Overall Survival (OS) [Срок оценки: 5 years from the date of surgery]
Вторичные конечные точки (5)
  • Progression-Free Survival (PFS) [Срок оценки: 5 years from the date of surgery]
  • Frequency of early postoperative complications [Срок оценки: 30 days post-surgery]
  • Frequency of late postoperative complications [Срок оценки: 180 days post-surgery]
  • Quality of Life assessment using the EORTC QLQ-C30 questionnaire [Срок оценки: Baseline (30 days pre-surgery) and 1 month, 3 months, 6 months ans 12 months post-surgery]
  • Number of days of postoperative hospital stay [Срок оценки: From the date of surgery until post-operative hospital discharge(assessed up to 30 days after surgery)]

Критерии участия

Критерии включения

\- Retrospective Arm:

  • Diagnosis of advanced or recurrent gynecologic cancer with vascular involvement requiring resection and/or reconstruction of major blood vessels, including:
  • Ovarian carcinoma
  • Cervical carcinoma
  • Endometrial carcinoma
  • Vulvar carcinoma
  • Uterine or other types of sarcomas with vascular involvement
  • Documented major vascular invasion, confirmed by preoperative imaging or intraoperative description.
  • Patients who underwent onco-vascular surgery for advanced or recurrent gynecologic cancers between January 1, 2017, and August 31, 2025.
  • Data Protection Impact Assessment (DPIA) approved for the management of retrospective data. (Deceased or untraceable patients will also be included to avoid selection bias, in accordance with Article 110 bis, paragraph 4 of the Italian Privacy Code. A DPIA will be produced and published on the Sponsor's website before study initiation, and patients who explicitly objected before death will not be included.)

Prospective Arm:

  • Age ≥18 years
  • Patients eligible for onco-vascular surgery for advanced or recurrent gynecologic cancers with vascular involvement, including:
  • Ovarian carcinoma
  • Cervical carcinoma
  • Endometrial carcinoma
  • Vulvar carcinoma
  • Uterine or other types of sarcomas
  • Documented major vascular invasion, confirmed by preoperative imaging or intraoperative description.
  • Signed informed consent.

Критерии исключения

  • Patients younger than 18 years of age
  • Patients with early-stage gynecologic cancers not eligible for onco-vascular surgery
  • Patients undergoing vascular resection due to accidental injury of blood vessels not directly related to tumor infiltration.
  • Patients who have previously undergone vascular surgery for reasons unrelated to the study, to avoid data overlap.

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Модель наблюдения
Когортное

Центры проведения

Италия · 2 центра
  • Istituto Nazionale Tumori IRCCS Fondazione G. Pascale — Naples
  • A.R.N.A.S. Ospedali Civico Di Cristina Benfratell — Palermo

Идентификаторы

NCT: NCT07267780 · ONCOVASCULAR SURGERY

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗